Drug Shortage Report for MIRVALA 21
Report ID | 172355 |
Drug Identification Number | 02410249 |
Brand name | MIRVALA 21 |
Common or Proper name | MIRVALA |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | ETHINYL ESTRADIOL DESOGESTREL |
Strength(s) | 0.0300MG 0.1500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 21 BLS |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-10-18 |
Estimated end date | 2022-11-11 |
Actual end date | 2022-11-04 |
Shortage status | Resolved |
Updated date | 2022-11-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-11-07 | French | Compare |
v3 | 2022-11-07 | English | Compare |
v2 | 2022-10-21 | French | Compare |
v1 | 2022-10-21 | English | Compare |
Showing 1 to 4 of 4